Litcius/Paper detail

MicroRNA-153-5p promotes the proliferation and metastasis of renal cell carcinoma via direct targeting of AGO1

Zeyan Li, Shuo Zhao, Shiqin Zhu, Yidong Fan

2021Cell Death and Disease28 citationsDOIOpen Access PDF

Abstract

MicroRNAs (miRNAs) have been demonstrated to affect the biological processes of cancers and showed great potential for prognostic biomarkers. In this study, we screened differentially expressed miRNAs in ccRCC based on three dimensions of metastasis, prognosis, and differential expression compared to normal tissue using bioinformatics algorithms. MiR-153-5p was identified as a candidate miRNA to promote ccRCC occurrence and progression. Clinically, we found that miR-153-5p was significantly upregulated and related to unfavorable clinical features in ccRCC. Besides, miR-153-5p served as an independent prognostic biomarker. Functionally, miR-153-5p depletion remarkably inhibited the proliferation and metastasis of ccRCC via the phosphatidylinositol 3-kinase (PI3K)/Akt signaling. Furthermore, AGO1 was proved to be a direct target of miR-153-5p. AGO1 is associated with favorable clinical features and exhibited independent prognostic value in ccRCC. Besides, we observed that AGO1 knockdown significantly promoted tumor proliferation and metastasis. Downregulation of AGO1 partly abolished the oncogenic effects of miR-153-5p knockdown. Furthermore, miR-153-5p combined with AGO1 showed more robust prognostic significance in ccRCC. In conclusion, we found that the newly identified miR-153-5p/AGO1 axis was responsible for tumor occurrence and progression via PI3K/Akt signaling, which may therefore provide promising therapeutic targets and prognostic biomarkers for patients with ccRCC.

Topics & Concepts

Gene knockdownmicroRNAClear cell renal cell carcinomaCancer researchDownregulation and upregulationMetastasisBiologyPI3K/AKT/mTOR pathwayProtein kinase BCell growthBiomarkerTumor progressionApoptosisSignal transductionCancerMedicineRenal cell carcinomaPathologyCell biologyGeneGeneticsMicroRNA in disease regulationRenal cell carcinoma treatmentFerroptosis and cancer prognosis